News
11-02-2010, 11:50 PM
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.
More... (http://www.news-medical.net/news/20101103/OncoMed-receives-2412-million-to-support-therapeutic-programs-under-QTDP-program.aspx)
More... (http://www.news-medical.net/news/20101103/OncoMed-receives-2412-million-to-support-therapeutic-programs-under-QTDP-program.aspx)